[Hepatitis B and C virus mutants--clinical relevance]

Area of Science:

• Virology
• Hepatology
• Infectious Diseases

Context:

• Recent identification of Hepatitis B virus (HBV) mutants and Hepatitis C virus (HCV) genotypes in patients with acute and chronic infections.
• Observed associations between viral mutations and clinical outcomes, including chronic active hepatitis, fulminant hepatitis, and hepatocellular carcinoma (HCC).

Purpose:

• To investigate the potential impact of specific HBV mutants and HCV genotypes on the clinical course of viral hepatitis.
• To explore how these viral variations influence infection clearance and response to antiviral therapies, such as alpha-interferon.
• To establish the precise contribution of distinct mutations and genotypes to the pathogenesis and progression of HBV and HCV infections.

Summary:

• Hepatitis B virus (HBV) mutants and Hepatitis C virus (HCV) genotypes have been identified in patients with varying infection statuses.
• These viral variants may influence disease progression, including the development of hepatocellular carcinoma (HCC), and affect treatment efficacy.
• The precise role of specific mutations and genotypes in the natural history of HBV and HCV infections requires further elucidation.

Impact:

• Understanding the role of viral mutations and genotypes can lead to more personalized treatment strategies for hepatitis B and C.
• Identifying specific viral markers may improve prediction of disease severity and prognosis, including the risk of developing HCC.
• This knowledge can enhance the development of targeted antiviral therapies and improve patient outcomes in managing chronic viral hepatitis.